← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

CBUS logoCibus, Inc.(CBUS)Earnings, Financials & Key Ratios

CBUS•NASDAQ
$1.59
$728M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryRoyalty and IP Monetization Vehicles
AboutCibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.Show more
  • Revenue$4M-14.6%
  • EBITDA-$62M+75.5%
  • Net Income-$127M+49.4%
  • EPS (Diluted)-2.78+74.3%
  • Gross Margin-62.76%-162.8%
  • EBITDA Margin-1691.15%+71.3%
  • Operating Margin-1853.92%+69.4%
  • Net Margin-3492.31%+40.8%
  • ROE-212.41%-84.3%
  • ROIC-61.47%+28.7%
  • Debt/Equity1.51+308.1%
  • Interest Coverage-1.93+74.5%
Technical→

CBUS Key Insights

Cibus, Inc. (CBUS) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 14 (bottom 14%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Sales declining 31.3% over 5 years
  • ✗Shares diluted 100.0% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CBUS Price & Volume

Cibus, Inc. (CBUS) stock price & volume — 10-year historical chart

Loading chart...

CBUS Growth Metrics

Cibus, Inc. (CBUS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years11.08%
5 Years-31.34%
3 Years185.12%
TTM-14.62%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM49.45%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM67.84%

Return on Capital

10 Years-61.21%
5 Years-70.01%
3 Years-66.55%
Last Year-21.82%

CBUS Recent Earnings

Cibus, Inc. (CBUS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
Mar 17, 2026
EPS
$0.42
Est $0.43
+2.3%
Revenue
$1M
Est $2M
-35.7%
Q4 2025
Nov 13, 2025
EPS
$0.44
Est $0.41
-7.3%
Revenue
$615,000
Est $2M
-62.6%
Q3 2025
Aug 14, 2025
EPS
$0.61
Est $0.69
+11.6%
Revenue
$933,000
Est $2M
-38.3%
Q2 2025
May 8, 2025
EPS
$0.74
Est $0.70
-5.7%
Revenue
$1M
Est $1M
-10.3%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 17, 2026
$0.42vs $0.43+2.3%
$1Mvs $2M-35.7%
Q4 2025Nov 13, 2025
$0.44vs $0.41-7.3%
$615,000vs $2M-62.6%
Q3 2025Aug 14, 2025
$0.61vs $0.69+11.6%
$933,000vs $2M-38.3%
Q2 2025May 8, 2025
$0.74vs $0.70-5.7%
$1Mvs $1M-10.3%
Based on last 12 quarters of dataView full earnings history →

CBUS Peer Comparison

Cibus, Inc. (CBUS) competitors in Royalty and IP Monetization Vehicles — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
PGEN logoPGENPrecigen, Inc.Direct Competitor1.29B4.40-9.36-36.95%-39.13%-5.9%0.14
RKDA logoRKDAArcadia Biosciences, Inc.Direct Competitor1.6M1.17-0.2313.27%-97.95%-80.74%0.02
SEED logoSEEDOrigin Agritech LimitedDirect Competitor8.76M1.17-1.13-20.52%-42.61%
APLD logoAPLDApplied Digital CorporationDirect Competitor12.65B44.20-38.1057.74%-43.49%-6.23%1.11
OFIX logoOFIXOrthofix Medical Inc.Direct Competitor489.36M12.19-5.352.85%-7.27%-13.44%0.51
CTVA logoCTVACorteva, Inc.Product Competitor54.89B81.7651.102.92%6.5%4.62%0.11
FMC logoFMCFMC CorporationProduct Competitor1.85B14.79-0.83-18.34%-72.93%-82.27%2.00
BIOX logoBIOXBioceres Crop Solutions Corp.Product Competitor30.61M0.48-0.59-28.3%-16.6%-16.7%0.94

Compare CBUS vs Peers

Cibus, Inc. (CBUS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PGEN

Most directly comparable listed peer for CBUS.

Scale Benchmark

vs DE

Larger-name benchmark to compare CBUS against a more recognizable public peer.

Peer Set

Compare Top 5

vs PGEN, RKDA, SEED, APLD

CBUS Income Statement

Cibus, Inc. (CBUS) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue508K236K7.3M23.85M25.99M157K1.82M4.26M3.64M
Revenue Growth %27.32%-53.54%2991.53%226.91%8.96%-99.4%1057.32%134.56%-14.62%
Cost of Goods Sold551K1.08M9.28M35.13M28.56M1.53M395K05.92M
COGS % of Revenue108.46%458.05%127.19%147.28%109.89%977.07%21.74%-162.76%
Gross Profit
-43K▲ 0%
-845K▼ 1865.1%
-1.98M▼ 134.8%
-11.28M▼ 468.3%
-2.57M▲ 77.2%
-1.38M▲ 46.4%
1.42M▲ 203.3%
4.26M▲ 199.7%
-2.28M▼ 153.6%
Gross Margin %-8.46%-358.05%-27.19%-47.28%-9.89%-877.07%78.26%100%-62.76%
Gross Profit Growth %-121.61%-1865.12%-134.79%-468.35%77.21%46.42%203.27%199.72%-153.59%
Operating Expenses26.3M28.35M37.69M32.56M26.76M20.99M320.31M262.66M65.18M
OpEx % of Revenue5176.57%12013.14%516.57%136.5%102.98%13371.34%17628.23%6162.79%1791.15%
Selling, General & Admin14.74M18.5M24.14M20.79M15.38M9.44M28.91M30.8M26.91M
SG&A % of Revenue2901.77%7841.1%330.84%87.16%59.19%6012.74%1591.3%722.6%739.35%
Research & Development11.56M9.85M12.21M11.08M11.34M11.55M42.37M50.43M44.2M
R&D % of Revenue2274.8%4172.03%167.39%46.46%43.62%7358.6%2331.7%1183.22%1214.56%
Other Operating Expenses001.34M685K19K0249.02M181.43M-5.92M
Operating Income
-25.79M▲ 0%
-28.11M▼ 9.0%
-39.67M▼ 41.1%
-43.83M▼ 10.5%
-29.33M▲ 33.1%
-22.37M▲ 23.7%
-318.88M▼ 1325.5%
-258.4M▲ 19.0%
-67.46M▲ 73.9%
Operating Margin %-5076.57%-11913.14%-543.76%-183.77%-112.87%-14248.41%-17549.97%-6062.79%-1853.92%
Operating Income Growth %-112.97%-9.02%-41.11%-10.48%33.08%23.74%-1325.49%18.97%73.89%
EBITDA-25.24M-27.03M-38.07M-41.96M-26.99M-20.84M-314.19M-251.54M-61.54M
EBITDA Margin %-4968.11%-11455.08%-521.74%-175.94%-103.88%-13271.34%-17291.69%-5901.85%-1691.15%
EBITDA Growth %-114.54%-7.12%-40.81%-10.24%35.67%22.81%-1407.92%19.94%75.53%
D&A (Non-Cash Add-back)551K1.08M1.61M1.87M2.34M1.53M4.69M6.86M5.92M
EBIT-25.72M-26.64M-38.12M-43.4M-27.77M-16.74M-318.75M-248.49M-67.46M
Net Interest Income-1K264K110K-878K-1.41M-27K-18.36M-33.56M-35.04M
Interest Income01.52M1.6M557K17K60K527K631K0
Interest Expense1K1.26M1.49M1.44M1.43M87K18.89M34.19M35.04M
Other Income/Expense-191K218K61K-1M133K5.48M-18.76M-24.29M-64.71M
Pretax Income
-25.98M▲ 0%
-27.9M▼ 7.4%
-39.61M▼ 42.0%
-44.84M▼ 13.2%
-29.2M▲ 34.9%
-16.89M▲ 42.2%
-337.64M▼ 1899.0%
-282.68M▲ 16.3%
-132.17M▲ 53.2%
Pretax Margin %-5114.17%-11820.76%-542.93%-187.98%-112.36%-10758.6%-18582.44%-6632.66%-3632.1%
Income Tax1K00000-4K29K29K
Effective Tax Rate %-0%0%0%0%0%0%0%-0.01%-0.02%
Net Income
-25.98M▲ 0%
-27.9M▼ 7.4%
-39.61M▼ 42.0%
-44.84M▼ 13.2%
-29.2M▲ 34.9%
-16.89M▲ 42.2%
-267.63M▼ 1484.4%
-251.39M▲ 6.1%
-127.08M▲ 49.4%
Net Margin %-5114.17%-11820.76%-542.93%-187.98%-112.36%-10758.6%-14729.06%-5898.36%-3492.31%
Net Income Growth %-114.96%-7.38%-41.99%-13.19%34.88%42.15%-1484.44%6.07%49.45%
Net Income (Continuing)-25.98M-27.9M-39.61M-44.84M-29.2M-16.89M-337.64M-282.71M-132.2M
Discontinued Operations000000000
Minority Interest00000044.82M5.67M0
EPS (Diluted)
-56.10▲ 0%
-45.46▲ 19.0%
-60.37▼ 32.8%
-66.16▼ 9.6%
-0.05▲ 99.9%
-0.03▲ 42.2%
-25.95▼ 88769.9%
-10.83▲ 58.3%
-2.78▲ 74.3%
EPS Growth %-146.92%18.97%-32.8%-9.59%99.92%42.18%-88769.86%58.27%74.33%
EPS (Basic)-56.10-45.46-60.37-66.16-0.05-0.03-25.95-10.83-2.78
Diluted Shares Outstanding463.07M613.67M656.11M677.65M578.47M578.47M10.31M23.22M457.57M
Basic Shares Outstanding463.07M613.67M656.11M677.65M578.47M578.47M10.31M23.22M457.57M
Dividend Payout Ratio---------

CBUS Balance Sheet

Cibus, Inc. (CBUS) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets57.46M95.52M63.52M39.59M15.18M4.13M35.22M16.95M12.07M
Cash & Short-Term Investments56.66M93.79M58.61M29M13.82M3.43M32.7M14.43M9.92M
Cash Only56.66M93.79M58.61M17.3M13.82M3.43M32.7M14.43M9.92M
Short-Term Investments00011.7M00000
Accounts Receivable167K46K1.12M4.89M00530K1.04M703K
Days Sales Outstanding119.9971.1456.1374.79--106.4789.1570.51
Inventory01.31M2.59M1.38M00000
Days Inventory Outstanding-444.01102.0314.37-----
Other Current Assets138K67K388K393K499K705K1.99M1.47M1.44M
Total Non-Current Assets14.71M23.27M24.58M23.74M22.01M18.29M509.19M333.12M292.98M
Property, Plant & Equipment14.35M21.85M23.21M22.86M21.73M18.13M37.46M44.69M27.86M
Fixed Asset Turnover0.04x0.01x0.31x1.04x1.20x0.01x0.05x0.10x0.13x
Goodwill000000434.9M253.47M232.52M
Intangible Assets00000158K35.41M33.58M31.68M
Long-Term Investments01.11M0000000
Other Non-Current Assets357K306K1.36M877K282K01.42M1.39M926K
Total Assets
72.17M▲ 0%
118.79M▲ 64.6%
88.1M▼ 25.8%
63.33M▼ 28.1%
37.19M▼ 41.3%
22.42M▼ 39.7%
544.41M▲ 2328.1%
350.07M▼ 35.7%
305.05M▼ 12.9%
Asset Turnover0.01x0.00x0.08x0.38x0.70x0.01x0.00x0.01x0.01x
Asset Growth %334.14%64.61%-25.84%-28.12%-41.27%-39.72%2328.13%-35.7%-12.86%
Total Current Liabilities4.25M7M7.2M6.95M4.85M1.66M21.32M19.88M16.86M
Accounts Payable1.02M818K1.08M929K1.26M340K6.13M5.96M8.07M
Days Payables Outstanding677.67276.242.369.6516.180.95.66K-497.31
Short-Term Debt1.35M00000833K436K3.17M
Deferred Revenue (Current)43K248K000107K1.21M932K536K
Other Current Liabilities78K1.77M2.24M2M2.71M403K5.29M5.87M5.09M
Current Ratio13.51x13.64x8.83x5.70x3.13x2.49x1.65x0.85x0.72x
Quick Ratio13.51x13.45x8.47x5.50x3.13x2.49x1.65x0.85x0.72x
Cash Conversion Cycle-238.96115.879.5-----
Total Non-Current Liabilities10.44M18.39M18.39M19.51M18.21M13.53M184.79M232.36M266.36M
Long-Term Debt0001.52M00536K226K29.88M
Capital Lease Obligations10.15M18.23M18.24M17.88M17.51M13.45M17.14M31.22M29.78M
Deferred Tax Liabilities-10.15M00000000
Other Non-Current Liabilities0163K150K113K702K79K167.12M200.91M236.48M
Total Liabilities14.69M25.39M25.59M26.45M23.06M15.19M206.12M252.24M283.22M
Total Debt10.15M18.48M18.6M19.76M17.88M13.91M24.62M36.29M33.04M
Net Debt-46.52M-75.31M-40.01M2.46M4.05M10.48M-8.08M21.85M23.12M
Debt / Equity0.18x0.20x0.30x0.54x1.26x1.92x0.07x0.37x1.51x
Debt / EBITDA---------
Net Debt / EBITDA---------
Interest Coverage-25789.00x-22.37x-26.63x-30.54x-20.50x-257.13x-16.88x-7.56x-1.93x
Total Equity
57.48M▲ 0%
93.4M▲ 62.5%
62.51M▼ 33.1%
36.88M▼ 41.0%
14.13M▼ 61.7%
7.23M▼ 48.8%
338.29M▲ 4577.1%
97.83M▼ 71.1%
21.83M▼ 77.7%
Equity Growth %338.11%62.5%-33.07%-41.01%-61.68%-48.82%4577.09%-71.08%-77.69%
Book Value per Share0.120.150.100.050.020.0132.804.210.05
Total Shareholders' Equity57.48M93.4M62.51M36.88M14.13M7.23M293.47M92.16M21.83M
Common Stock3K3K3K4K4K5K8K9K79K
Retained Earnings-54.55M-82.44M-122.06M-166.89M-196.09M-212.15M-479.78M-731.17M-858.25M
Treasury Stock0-230K-1.04M-1.04M-1.04M-1.04M-1.78M-2M-2.14M
Accumulated OCI-1.28M-2.09M17K0008K15K39K
Minority Interest00000044.82M5.67M0

CBUS Cash Flow Statement

Cibus, Inc. (CBUS) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-12.79M-20.25M-31.95M-43.67M-18.81M-19.36M-46.21M-58.04M-50.59M
Operating CF Margin %-2516.73%-8581.36%-437.92%-183.1%-72.39%-12333.76%-2543.2%-1361.87%-1390.24%
Operating CF Growth %-38.41%-58.4%-57.77%-36.68%56.93%-2.94%-138.64%-25.61%12.84%
Net Income-25.98M-27.9M-39.61M-44.84M-29.2M-16.89M-267.63M-282.71M-127.08M
Depreciation & Amortization551K1.08M1.61M1.87M2.34M1.53M4.69M6.86M5.92M
Stock-Based Compensation12.09M4.38M9.18M4.97M2.09M4M010.75M8.19M
Deferred Taxes000000000
Other Non-Cash Items12.42M11K00-1.53M-5.12M215.76M206.68M60.06M
Working Capital Changes552K2.17M-3.12M-5.68M7.49M-2.88M961K383K2.32M
Change in Receivables110K0-1.12M-3.77M4.89M01.7M-512K538K
Change in Inventory667K0-2.59M1.21M1.38M0000
Change in Payables665K-193K259K-148K-360K-229K2K-188K720K
Cash from Investing-779K-1.8M-2.97M-13.48M11.2M-1.52M55.06M-808K-578K
Capital Expenditures-779K-1.85M-2.97M-1.79M-497K-1.52M-4.32M-808K-578K
CapEx % of Revenue153.35%782.63%40.69%7.49%1.91%968.15%237.81%18.96%15.88%
Acquisitions00000059.38M00
Investments---------
Other Investing050K0-11.7M11.7M0000
Cash from Financing65.2M60.67M-330K15.41M3.74M9.99M20.32M40.6M46.65M
Debt Issued (Net)6.96M1.24M139K1.16M-364K-376K-194K-879K-1.11M
Equity Issued (Net)1000K1000K344K1000K1000K1000K1000K1000K1000K
Dividends Paid000000000
Share Repurchases0-230K0000000
Other Financing01.73M-813K-751K-274K-1.17M1.76M-2.42M-142K
Net Change in Cash
51.64M▲ 0%
38.62M▼ 25.2%
-35.18M▼ 191.1%
-41.75M▼ 18.7%
-3.87M▲ 90.7%
-10.89M▼ 181.7%
29.17M▲ 367.8%
-18.27M▼ 162.6%
-4.51M▲ 75.3%
Free Cash Flow
-13.56M▲ 0%
-22.1M▼ 62.9%
-34.92M▼ 58.0%
-45.46M▼ 30.2%
-19.31M▲ 57.5%
-20.88M▼ 8.2%
-50.53M▼ 142.0%
-58.85M▼ 16.5%
-51.17M▲ 13.1%
FCF Margin %-2670.08%-9363.98%-478.62%-190.59%-74.3%-13301.91%-2781.01%-1380.83%-1406.13%
FCF Growth %31.01%-62.92%-58.02%-30.18%57.53%-8.16%-141.96%-16.47%13.05%
FCF per Share-0.03-0.04-0.05-0.07-0.03-0.04-4.90-2.53-0.11
FCF Conversion (FCF/Net Income)0.49x0.73x0.81x0.97x0.64x1.15x0.17x0.23x0.40x
Interest Paid0001.46M1.43M0000
Taxes Paid000000000

CBUS Key Ratios

Cibus, Inc. (CBUS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)-64.67%-73.6%-36.98%-50.82%-90.23%-114.49%-158.12%-154.91%-115.28%-212.41%
Return on Invested Capital (ROIC)-237.03%-203.03%-145.18%-146.63%-106.33%-76.49%-93.46%-137.48%-86.15%-61.47%
Gross Margin49.87%-8.46%-358.05%-27.19%-47.28%-9.89%-877.07%78.26%100%-62.76%
Net Margin-3029.07%-5114.17%-11820.76%-542.93%-187.98%-112.36%-10758.6%-14729.06%-5898.36%-3492.31%
Debt / Equity-0.18x0.20x0.30x0.54x1.26x1.92x0.07x0.37x1.51x
Interest Coverage-2421.80x-25789.00x-22.37x-26.63x-30.54x-20.50x-257.13x-16.88x-7.56x-1.93x
FCF Conversion0.76x0.49x0.73x0.81x0.97x0.64x1.15x0.17x0.23x0.40x
Revenue Growth-68.63%27.32%-53.54%2991.53%226.91%8.96%-99.4%1057.32%134.56%-14.62%

CBUS SEC Filings & Documents

Cibus, Inc. (CBUS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 10, 2026·SEC

Material company update

Mar 27, 2026·SEC

Material company update

Mar 17, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 17, 2026·SEC

FY 2025

Mar 20, 2025·SEC

FY 2024

Mar 21, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 14, 2025·SEC

FY 2025

May 8, 2025·SEC

CBUS Frequently Asked Questions

Cibus, Inc. (CBUS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Cibus, Inc. (CBUS) reported $3.6M in revenue for fiscal year 2025. This represents a 186% increase from $1.3M in 2015.

Cibus, Inc. (CBUS) saw revenue decline by 14.6% over the past year.

Cibus, Inc. (CBUS) reported a net loss of $127.1M for fiscal year 2025.

Dividend & Returns

Cibus, Inc. (CBUS) has a return on equity (ROE) of -212.4%. Negative ROE indicates the company is unprofitable.

Cibus, Inc. (CBUS) had negative free cash flow of $51.2M in fiscal year 2025, likely due to heavy capital investments.

Explore More CBUS

Cibus, Inc. (CBUS) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.